Table 2.
Men | Women <40 years old | Women ≥40 years old | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N | ART initiation | N | ART initiation | n | ART initiation | |||||||
% | OR* | 95 % CI | % | OR* | 95 % CI | % | OR* | 95 % CI | ||||
CD4 = 0–200 cells/μL | ||||||||||||
Entry period | ||||||||||||
Period 1 | 3 251 | 53.8 | 1.00 | - | 4 136 | 48.3 | 1.00 | - | 1 290 | 58.1 | 1.00 | - |
Period 2 | 1 324 | 51.4 | 0.91 | 0.80-1.03 | 1 537 | 49.3 | 1.04 | 0.93-1.17 | 408 | 59.3 | 1.05 | 0.84-1.32 |
Period 3 | 1 134 | 56.8 | 1.13 | 0.98-1.29 | 1 070 | 49.9 | 1.07 | 0.93-1.22 | 319 | 52.3 | 0.79 | 0.62-1.01 |
CD4 = 201–350 cells/μL | ||||||||||||
Entry period | ||||||||||||
Period 1 | 1 411 | 6.9 | 1.00 | - | 3 524 | 6.0 | 1.00 | - | 925 | 6.9 | 1.00 | - |
Period 2 | 611 | 10.3 | 1.56 | 1.12-2.17 | 1 297 | 20.0 | 3.90 | 3.21-4.73 | 250 | 8.4 | 1.23 | 0.74-2.06 |
Period 3 | 658 | 41.8 | 9.73 | 7.52-12.59 | 1 265 | 39.6 | 10.19 | 8.53-12.19 | 240 | 41.7 | 9.61 | 6.70-13.79 |
Period 1: January 1, 2007–March 31, 2010; Period 2: April 1, 2010–July 31, 2011; Period 3: August 1, 2011–September 15, 2012
OR: Odd-Ratio; 95 % CI: 95 % Confidence Interval
* Logistic regression
HIV Hlabisa Programme, KwaZulu-Natal, South Africa. 2007–2012